Results 131 to 140 of about 365,500 (282)
Isolated senile plaque cores in Alzheimer's disease and Down's syndrome show differences in morphology. [PDF]
David Allsop+3 more
openalex +1 more source
Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics
Abstract Before the controversial approval of humanized monoclonal antibody lecanemab, which binds to the soluble amyloid‐β protofibrils, all the treatments available earlier, for Alzheimer's disease (AD) were symptomatic. The researchers are still struggling to find a breakthrough in AD therapeutic medicine, which is partially attributable to lack in ...
Sharif Arar+2 more
wiley +1 more source
Background: Alois Alzheimer is a Bavarian born German psychiatrist who is considered as the “Father of Neuropathology” was the first to describe the main neuro pathologic characteristics of the peculiar disease in the brain of a woman showing progressive
Padmapriya Gorjilli
doaj
The γ-secretase complex is a major therapeutic target for the prevention and treatment of Alzheimer's disease. Previous studies have shown that treatment of young APP mice with specific inhibitors of γ-secretase prevented formation of new plaques. It has
Golde Todd E+8 more
doaj +1 more source
Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice. [PDF]
BackgroundAlzheimer disease (AD) is characterized by the accumulation of beta-amyloid (Aβ) plaques and neurofibrillary tangles composed of hyperphosphorylated tau, which together lead to neurodegeneration and cognitive decline.
Agadjanyan, Michael G+14 more
core
ATHEROSCLEROTIC CHANGES OF BRACHIOCEPHALIC ARTERIES IN DIFFERENT AGE GROUPS ACCORDING TO SONOGRAPHY
Background. One of the most frequent causes of death is considered to be stroke on the back of atherosclerosis of the extracranial carotid arteries. Detection of atherosclerosis at an early stage facilitates timely prevention and reduces the risk of ...
Anna P. Boreyko+2 more
doaj +1 more source
Alzheimer disease and platelets: how’s that relevant
Alzheimer Disease (AD) is the most common neurodegenerative disorder worldwide, and account for 60% to 70% of all cases of progressive cognitive impairment in elderly patients.
Catricala Silvia+2 more
doaj +1 more source
Augmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic Mice [PDF]
Michael J. Callahan+5 more
openalex +1 more source
Pathological hallmarks of Alzheimer’s disease (AD) include senile plaques, neurofibrillary tangles (NFTs), synaptic loss, and neurodegeneration. Senile plaques are composed of amyloid-β (Aβ) and are surrounded by microglia, a primary immune effector cell
Kazuyuki Takata, Yoshihisa Kitamura
doaj
The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease
Alzheimer's disease is the most common cause of dementia in the elderly, and manifests as progressive cognitive decline and profound neuronal loss.
Landreth Gary E, Wilkinson Brandy L
doaj +1 more source